- Home
- PHIO
PHIO
Phio Pharmaceuticals Corp.
as 04-25-2025 4:00pm EST
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | MARLBOROUGH |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $4.00 | AVG Volume (30 days): | 8.8M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -9.08 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.97 - $9.79 | Next Earning Date: | 05-08-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Phio Pharmaceuticals Corp. News
PHIO Breaking Stock News: Dive into PHIO Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
Best Momentum Stocks to Buy for April 23rd
Zacks
3 days ago
Best Value Stocks to Buy for April 23rd
Zacks
16 days ago
PHIO Stock Soars as Safety Panel Clears Skin Cancer Drug for Next Dose
MT Newswires
17 days ago
Sector Update: Health Care Stocks Fall Premarket Wednesday
MT Newswires
17 days ago
Phio Pharmaceuticals Potential Skin Cancer Treatment Recommended for Dose Escalation
Newsfile
17 days ago
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Study to Fourth Dose Escalation Cohort
Newsfile
23 days ago
Phio Pharmaceuticals Announces Podium Presentations on INTASYL siRNA Lead Product Candidates PH-762 and PH-894
Newsfile
a month ago
Phio Pharmaceuticals Reports 2024 Year End Financial Results and Provides Business Update
Compare PHIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PHIO Phio Pharmaceuticals Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.